Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair
WP Lafuse, DJ Wozniak, MVS Rajaram - Cells, 2020 - mdpi.com
The immune system plays a pivotal role in the initiation, development and resolution of
inflammation following insult or damage to organs. The heart is a vital organ which supplies …
inflammation following insult or damage to organs. The heart is a vital organ which supplies …
Inflammation and fibrosis in murine models of heart failure
L Bacmeister, M Schwarzl, S Warnke, B Stoffers… - Basic research in …, 2019 - Springer
Heart failure is a consequence of various cardiovascular diseases and associated with poor
prognosis. Despite progress in the treatment of heart failure in the past decades, prevalence …
prognosis. Despite progress in the treatment of heart failure in the past decades, prevalence …
[HTML][HTML] Physiology, renin angiotensin system
JH Fountain, J Kaur, SL Lappin - 2017 - europepmc.org
The renin-angiotensin-aldosterone system (RAAS) is a critical regulator of blood volume,
electrolyte balance, and systemic vascular resistance. While the baroreceptor reflex …
electrolyte balance, and systemic vascular resistance. While the baroreceptor reflex …
Wound healing: a comprehensive review
YH Almadani, J Vorstenbosch… - Seminars in plastic …, 2021 - thieme-connect.com
Wound healing is an intricate, tightly regulated process that is critical to maintaining the
barrier function of skin along with preserving all other skin functions. This process can be …
barrier function of skin along with preserving all other skin functions. This process can be …
From inflammation to fibrosis—molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities
N Suthahar, WC Meijers, HHW Silljé… - Current heart failure …, 2017 - Springer
Abstract Purpose of Review In this review, we highlight the most important cellular and
molecular mechanisms that contribute to cardiac inflammation and fibrosis. We also discuss …
molecular mechanisms that contribute to cardiac inflammation and fibrosis. We also discuss …
Biomarkers for the identification of cardiac fibroblast and myofibroblast cells
Experimental research has recognized the importance of cardiac fibroblast and
myofibroblast cells in heart repair and function. In a normal healthy heart, the cardiac …
myofibroblast cells in heart repair and function. In a normal healthy heart, the cardiac …
Mechanisms of metabolic acidosis–induced kidney injury in chronic kidney disease
DE Wesson, JM Buysse… - Journal of the American …, 2020 - journals.lww.com
Retrospective analyses and single-center prospective studies identify chronic metabolic
acidosis as an independent and modifiable risk factor for progression of CKD. In patients …
acidosis as an independent and modifiable risk factor for progression of CKD. In patients …
Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis
Q Lu, Z Ma, YE Ding, T Bedarida, L Chen, Z Xie… - Nature …, 2019 - nature.com
Although angiotensin II (AngII) is known to cause renal injury and fibrosis, the underlying
mechanisms remain poorly characterized. Here we show that hypertensive nephropathy …
mechanisms remain poorly characterized. Here we show that hypertensive nephropathy …
Targeting the renin-angiotensin-aldosterone system in fibrosis
Fibrosis is characterized by excessive deposition of extracellular matrix components such as
collagen in tissues or organs. Fibrosis can develop in the heart, kidneys, liver, skin or any …
collagen in tissues or organs. Fibrosis can develop in the heart, kidneys, liver, skin or any …
Therapies for thoracic aortic aneurysms and acute aortic dissections: old controversies and new opportunities
DM Milewicz, F Ramirez - Arteriosclerosis, Thrombosis, and …, 2019 - Am Heart Assoc
Thoracic aortic aneurysms that progress to acute aortic dissections are often fatal. Thoracic
aneurysms have been managed with treatment with β-adrenergic blocking agents (β …
aneurysms have been managed with treatment with β-adrenergic blocking agents (β …